MedPath

A pilot study of the evaluation of the combine use of bovine derived zenograft bone and platelet-rich fibrin membrane as grafting material for vertical alveolar ridge augmentation with simultaneous implant placement in posterior mandible area

Not Applicable
Recruiting
Conditions
&#45
vertical bone defect in the edentulous area where single tooth implant placement is needed
Platelet&#45
rich fibrin
Vertical bone augmentation
Guided bone regeneration
Implant placement
Bone augmentation
Registration Number
TCTR20140311001
Lead Sponsor
Khon Kaen University research fund
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
20
Inclusion Criteria

a.Healthy subject without any present systemic disease or medical condition which can affect the prognosis and surgical procedure e.g. bleeding disorders, uncontrolled diabetes mellitus, osteoporosis, hypertension.
b.Patient has to be above 20 years old
c.Patient desire for single implant placement on the lower posterior region (molars).
d.Implant site with at least 1 walls bone defect, inadequate bone height of at least 2 mm. compare with the crestal bone of adjacent teeth, and about 3-4 months post extraction area. ( evaluate from the x-ray)
e.The opposing teeth are natural teeth.
f.Patient can be followed up the dental implant for 1 year

Exclusion Criteria

a.Pregnant woman
b.Mental disorders
c.Active smoker (more than 10 cigarettes a day)
d.Severe chronic periodontitis patient.
e.Active bisphosphonate users.
f.Taking anticoagulant drugs.
g.Severe bruxer

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Alveolar bone height gained 1, 3, 6 months Screen calipers 4.0 ( Iconico Inc., Japan)
Secondary Outcome Measures
NameTimeMethod
Alveolar bone height 1 year Screen calipers 4.0 (Iconico In., Japan)c
© Copyright 2025. All Rights Reserved by MedPath